The preferential inhibition of 5-lipoxygenase product formation by benoxaprofen.
D000818:Animals; D001091:Arachidonate Lipoxygenases; D001202:Ascitic Fluid / Q000166:cytology; D001792:Blood Platelets / Q000201:enzymology*; D002460:Cell Line; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007942:Leukemia, Experimental / Q000201:enzymology; D016859:Lipoxygenase Inhibitors; D008861:Microsomes / Q000201:enzymology; D011422:Propionates / Q000494:pharmacology*
D016859:Lipoxygenase Inhibitors; D011422:Propionates; C011677:benoxaprofen; D001091:Arachidonate Lipoxygenases; D007213:Indomethacin